IPO

Due to massive investor demand, Western Copper and Gold upsized its financing to C$80M, fueling the critical next steps for its giant Casino copper-gold project.

A mid-market bank's AI deal reveals a larger trend: how specialized financiers are becoming the crucial, unseen engine behind tech's next evolution.

Datasea's profits are booming despite a revenue drop, as it pivots to high-margin AI and futuristic acoustic tech. Is this a genius move or a risky gamble?

Granted a 180-day extension, the APAC entertainment firm battles a low stock price despite revenue growth and strategic pivots in a booming market.

A 37-year-old patient receives a successful heart transplant at UCSF after being sustained by a SynCardia Total Artificial Heart, a major clinical win.

With $255M from star investors, a firm is betting on a radical idea: that treating employees with dignity is the best way to generate returns.

A new oral drug, IMSB301, offers hope for Aicardi Goutières Syndrome, a devastating rare disease with no cure, in a pivotal new clinical trial.

A new plant-derived drug shows promise in preventing prostate cancer and improving cholesterol, but the company faces significant financial hurdles ahead.

The iconic brand is pivoting from its print legacy to a diversified lifestyle empire, and it has a new plan to convince investors it's the right move.

With promising new data for its cancer and obesity pipeline, Corbus Pharmaceuticals prepares for a crucial investor presentation at the Oppenheimer conference.

Gilat DataPath will supply advanced, combat-proven SATCOM terminals to a European MoD, marking a key expansion in the region's push for digital sovereignty.

Crypto giants BitGo and 21shares expand their global partnership, building regulated infrastructure to meet surging institutional demand for digital assets.

Vietnam's FPT earns its second recognition in a key Gartner Market Guide, validating its AI-driven strategy and deep expertise in a crowded M365 market.

Proem Acquisition Corp I launches a $130M IPO, led by tech IPO guru Imran Khan. But can it succeed in a revived, yet risk-laden, SPAC landscape?

With a strong cash position, Arcus Biosciences heads into a pivotal year as investors await critical data on its promising cancer and autoimmune pipeline.

Gloo's major sponsorship of NRB 2026 signals a new era of AI in faith, but raises critical questions about technology's role in modern spirituality.

Social Commerce Partners Corp. begins separate trading for its shares and warrants, a key step as it navigates a tough market to find a target in direct selling.

Following key FDA progress for its oral osteoporosis drug, Entera Bio's CEO and board members are buying up company stock, signaling deep confidence.

As a wave of old solar panels looms, Comstock Inc. is betting on a certified zero-landfill recycling facility. Can this green venture save its financials?

HeartCore Enterprises forecasts a dramatic swing to profitability in 2025 after divesting its software unit, betting its future on IPO consulting.